Bliv Tirzepatide Cost: What You Actually Pay Per Month and Per Year

Wait — which Bliv is this, exactly?

"Bliv" isn't a name you've necessarily seen before, and it isn't unique to healthcare — it shows up attached to unrelated apps and businesses elsewhere online. The Bliv this page is about is joinbliv.com, run by Bliv Wellness LLC, doing business as Bliv, headquartered in Ogden, Utah since it incorporated in November 2022. It's a telehealth platform built around GLP-1 prescriptions — semaglutide and tirzepatide, both compounded and brand-name — filled out entirely online with no phone call or video visit required. If you also see a physical med-spa called Bliv Aesthetics & Wellness in Ogden, that's the same company's in-person location, not a different business borrowing the name.

How much does Bliv's tirzepatide cost per month?

Bliv's compounded tirzepatide is listed starting at $199 a month. That's the number on the homepage, the dedicated pricing page, and the tirzepatide-specific landing page — consistent across the site as of this writing. Compounded semaglutide, the single-mechanism alternative, starts lower at $116 a month.

• Compounded tirzepatide: starting at $199/mo
• Compounded semaglutide: starting at $116/mo
• Both described as prepared and dispensed by a licensed U.S. pharmacy under a valid prescription
• Free shipping advertised on every plan

The word "starting" is doing real work in that sentence, and it's worth sitting with before comparing Bliv to anything else. Unlike Henry Meds or Mochi Health, which publish a single flat price or a clear per-dose table, Bliv doesn't show what a maintenance-dose vial costs anywhere on its public marketing pages. The $199 figure is the floor, not necessarily the number that ends up on your card by month four or five.

Is there a membership fee, or is the price all-in?

On the compounded track — the $199/mo tirzepatide and $116/mo semaglutide — Bliv does not advertise a separate membership charge. The site's language is explicit: "no contracts, hidden fees, or long-term commitments." That puts Bliv's compounded pricing model closer to Henry Meds' all-in structure than to Mochi Health, Ro, or Hims, all three of which bill a membership fee on a separate schedule from the medication itself.

That said, Bliv runs a second, entirely separate pricing track for patients who want FDA-approved brand-name medication instead of a compounded version. On that track, Zepbound and Wegovy are billed alongside a membership fee — $83 a month on a 3-month commitment, $74 a month on 6 months, or $70 a month on a 12-month term — plus the drug cost on top. Zepbound on this track starts at $299 the first month and rises to $399–$449; Wegovy runs $149–$299 as the oral pill or $199–$349 as the injectable pen, depending on dose. It's easy to land on the wrong page and think you're pricing the same product twice; you're not. The two tracks have different pricing structures entirely.

What's actually included in the $199 a month?

Based on what Bliv publishes, the $199 covers the compounded tirzepatide itself, review of your intake by a U.S.-licensed provider, and shipping to your door — typically within three to five days, according to the site. There's no separate line item for the provider review or the delivery; both are folded into the one number.

• Compounded tirzepatide, filled through a U.S. pharmacy
• Provider review of your online intake (no video call required)
• Shipping, included at no extra charge
• Access to Bliv's lifestyle coaching and educational resources, per the site's program description

That last point is worth a caveat: Bliv markets "lifestyle coaching" and a "supportive community" as part of the broader weight-loss program, but the specifics of what that coaching looks like in practice — frequency, format, whether it's a dietitian or a general coach — aren't spelled out on the pricing pages themselves.

What's not included — insurance, labs, and other real costs

As with essentially every compounded GLP-1 telehealth platform, Bliv's medication isn't billed to insurance — compounded semaglutide and tirzepatide don't carry an insurance-payable NDC the way an FDA-approved drug does. Lab work also isn't part of the advertised price; if your provider wants baseline or monitoring bloodwork, that's arranged and paid for separately, either through your own primary care provider or a direct-pay lab, which commonly runs somewhere in the $40-$100 per draw range at independent labs as a general market figure rather than a Bliv-specific quote.

• Insurance: not billed for compounded medication, consistent with the rest of the category
• Lab work: not bundled into the monthly price
• Multi-month prepay terms and cancellation policy for the compounded track: not fully itemized in public materials — confirm directly before committing past month-to-month
• Coupon codes, per BBB complaints, have reportedly been difficult to apply after an order is already placed

None of that makes Bliv unusual for this category — no compounded GLP-1 provider bundles labs as standard, and none takes insurance for the medication itself. The gap that's more specific to Bliv is the pricing transparency above the starting dose, which several competitors handle differently.

Does the price climb as your tirzepatide dose goes up?

This is the honest answer: it's unclear from what Bliv publishes, and that ambiguity is itself worth flagging. Bliv doesn't post a dose-by-dose price table for compounded tirzepatide the way Henry Meds, Ro, or Hims do for their own medications. What is documented, through Better Business Bureau complaints, is that Bliv bills tirzepatide by the vial rather than prorating cost to your exact prescribed dose — one complaint described receiving a vial with far less medication than expected relative to what was paid for a multi-month supply. That's a different problem from a price increase, but it points the same direction: what you pay per milligram isn't fixed and transparent the way a flat-rate competitor's is.

If a flat, dose-independent price matters to you specifically, that's the model Mochi Health is built around — its tirzepatide holds one price at every dose level, a structural difference worth knowing before you compare the two headline numbers side by side.

How much does a year of Bliv tirzepatide cost, all-in?

At the published starting price with no dose increase, the math is straightforward: $199 a month times twelve comes to $2,388 a year. That is a floor, not a forecast — most patients on tirzepatide do titrate upward over the course of a year as their provider adjusts their dose, and because Bliv doesn't publish what a maintenance-dose vial costs, there's no way to responsibly project a realistic full-year number from public information alone.

• Starting-dose tirzepatide: $199/mo x 12 = $2,388/yr (confirmed floor)
• Semaglutide, for comparison: $116/mo x 12 = $1,392/yr (confirmed floor)
• Add roughly $100-$400/yr if you're paying out of pocket for monitoring labs
• Realistic full-year total at a maintenance dose: not publicly disclosed by Bliv — ask directly before budgeting past the starting tier

That's a meaningfully different situation from Henry Meds or Mochi Health, where the flat monthly rate means the twelve-times-monthly math actually holds up as a realistic annual estimate, dose changes included.

Any coupon, discount, or way to lower the price?

Bliv offers two buy-now-pay-later options at checkout — CareCredit, with 24 months at 0% APR for qualifying applicants, and Klarna, which splits payments into smaller installments advertised as low as $29 a month. Both are financing tools that spread the same total cost over time rather than genuine discounts, and approval depends on the lender's own credit check, not Bliv. On the branded track, committing to a longer membership term lowers the monthly membership fee from $83 (3 months) to $74 (6 months) to $70 (12 months) — though that's a discount on the membership only, not on the drug price itself. Beyond that, Bliv doesn't publish an ongoing coupon or referral program on its pricing pages.

How does Bliv's tirzepatide pricing compare to Henry Meds, Mochi Health, Ro, and Hims?

Henry Meds — all-in pricing, no dose ambiguity

Henry Meds charges $349 a month for oral compounded tirzepatide or $449 for the injectable version, all-in, with no separate membership fee and — critically — no price increase as your dose climbs from starting to maintenance. Bliv's $199 starting price undercuts both Henry Meds figures at the entry dose, but Henry Meds' flat structure means its number is the real annual number, not a floor. Full pricing in the Henry Meds cost guide.

Mochi Health — a published per-dose range instead of a single starting price

Mochi bills a $79/mo membership separately from medication, and its compounded tirzepatide runs $90 to $199 a month by dose — landing between roughly $169 and $278 a month all-in depending on where you fall in that range. At the lowest dose tier, Mochi's all-in price is close to Bliv's $199 starting price; at higher doses, Mochi is still itemized and predictable in a way Bliv's public pricing currently isn't. See the Mochi Health cost guide for the full per-dose breakdown.

Ro — brand-name only, a much higher floor

Ro doesn't sell compounded tirzepatide at all. Its only tirzepatide option is FDA-approved Zepbound, priced at $299 the first month and rising to $399-$449 a month by dose. On top of that, Ro charges a $149/mo membership ($39 the first month). All-in, most Ro tirzepatide patients land between roughly $548 and $598 a month — several times Bliv's compounded starting price, though the trade-off is an FDA-approved product with Ro's insurance-concierge support. Details in the Ro cost breakdown.

Hims — also brand-name, membership billed apart from medication

Hims exited compounded semaglutide for new patients in 2026. It now sells brand-name Zepbound starting around $299 a month and climbing toward $449 at higher doses, plus a $149/mo membership. All-in, that's roughly $448 to $598 a month — in the same range as Ro, and well above Bliv's compounded pricing. Full numbers in the Hims review.

Bliv's own branded Zepbound track, worth noting here, sits closer to Ro and Hims than to its own compounded pricing: $299 starting, $399-$449 thereafter, plus a $70-$83/mo membership — roughly $369 to $532 a month all-in depending on dose and commitment term. The takeaway across all four comparisons: Bliv's compounded tirzepatide is priced to compete at the entry dose, but it's the least transparent of the group about what a full course of treatment actually costs once you're past month one.

Is Bliv worth it for tirzepatide, or should you look elsewhere?

Bliv is a real, operating company — BBB-accredited with an A rating since March 2024, a company history dating to 2022, and a solidly positive Trustpilot record (4.3 out of 5 across more than 2,100 reviews, with fast shipping and provider responsiveness as the most repeated praise). It's not a scam or a shell operation. Two things are worth weighing against that: the FDA issued a warning letter to Bliv Wellness LLC in February 2026 over how its compounded semaglutide and tirzepatide were labeled and marketed — part of a broader FDA sweep against compounding telehealth platforms rather than a Bliv-specific singling-out, but a real regulatory record nonetheless. And a share of BBB complaints describe billing and fulfillment friction: coupon codes that didn't apply after checkout, orders that couldn't be canceled once they reached the pharmacy, and at least one report of a vial containing less medication than expected.

For a woman comparing entry-level compounded tirzepatide prices and who wants the lowest possible starting number with a fast, no-video intake, Bliv's $199/mo is a legitimate contender worth putting next to Mochi's per-dose range. For anyone who wants to see the full cost of a year of treatment mapped out before they enroll — dose increases included — Henry Meds' flat all-in pricing or Mochi's published per-dose table currently give a clearer picture than Bliv does.